buprenorphine transdermal system

Product NDC: 47781-419
11-digit product format: 477810419
Labeler code: 47781
Product ID: 47781-419_7f83c8aa-7590-e2fe-4998-55323eadd112
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: buprenorphine
Dosage form: PATCH, EXTENDED RELEASE
Route: TRANSDERMAL
Labeler: Alvogen Inc.
Application: ANDA207490
Marketing category: ANDA
Marketing start: 2022-05-17
Marketing end: 2027-01-31
Substance: BUPRENORPHINE
Active strength: 15 ug/h
Pharmacologic classes: Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]
DEA schedule: CIII
NDC exclude flag: No
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A207490-001	BUPRENORPHINE	BUPRENORPHINE	5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17
A207490-002	BUPRENORPHINE	BUPRENORPHINE	10MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17
A207490-003	BUPRENORPHINE	BUPRENORPHINE	15MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17
A207490-004	BUPRENORPHINE	BUPRENORPHINE	20MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17
A207490-005	BUPRENORPHINE	BUPRENORPHINE	7.5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL		2023-03-21

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A207490-001	AB
A207490-002	AB
A207490-003	AB
A207490-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 139 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A207490-001	BUPRENORPHINE	5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207490-002	BUPRENORPHINE	10MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207490-003	BUPRENORPHINE	15MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207490-004	BUPRENORPHINE	20MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207490-005	BUPRENORPHINE	7.5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL		2023-03-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207490-001	BUPRENORPHINE	5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207490-002	BUPRENORPHINE	10MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207490-003	BUPRENORPHINE	15MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207490-004	BUPRENORPHINE	20MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207490-005	BUPRENORPHINE	7.5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL		2023-03-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A207490-001	BUPRENORPHINE	5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207490-002	BUPRENORPHINE	10MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207490-003	BUPRENORPHINE	15MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207490-004	BUPRENORPHINE	20MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207490-005	BUPRENORPHINE	7.5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL		2023-03-21	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207490-001	BUPRENORPHINE	5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207490-002	BUPRENORPHINE	10MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207490-003	BUPRENORPHINE	15MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207490-004	BUPRENORPHINE	20MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207490-005	BUPRENORPHINE	7.5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL		2023-03-21	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207490-001	BUPRENORPHINE	5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207490-002	BUPRENORPHINE	10MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207490-003	BUPRENORPHINE	15MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207490-004	BUPRENORPHINE	20MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207490-005	BUPRENORPHINE	7.5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL		2023-03-21	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207490-001	BUPRENORPHINE	5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207490-002	BUPRENORPHINE	10MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207490-003	BUPRENORPHINE	15MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207490-004	BUPRENORPHINE	20MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207490-005	BUPRENORPHINE	7.5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL		2023-03-21	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207490-001	BUPRENORPHINE	5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207490-002	BUPRENORPHINE	10MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207490-003	BUPRENORPHINE	15MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207490-004	BUPRENORPHINE	20MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207490-005	BUPRENORPHINE	7.5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL		2023-03-21	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207490-001	BUPRENORPHINE	5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207490-002	BUPRENORPHINE	10MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207490-003	BUPRENORPHINE	15MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207490-004	BUPRENORPHINE	20MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL	AB	2022-05-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207490-005	BUPRENORPHINE	7.5MCG/HR	FILM, EXTENDED RELEASE / TRANSDERMAL		2023-03-21	`5bbf6a4d5a75…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 119 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A207490-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207490-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207490-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207490-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207490-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207490-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207490-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207490-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A207490-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207490-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207490-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207490-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207490-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207490-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207490-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207490-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207490-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207490-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207490-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207490-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207490-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207490-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207490-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207490-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207490-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207490-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207490-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207490-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207490-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207490-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207490-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207490-004	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207490-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207490-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207490-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207490-004	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A207490-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A207490-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A207490-003	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A207490-004	AB	1	`d06236e962d9…`

Additional Listing Data#

Finished product: Yes
Brand name base: buprenorphine transdermal system

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
BUPRENORPHINE	15 ug/h

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
40D3SCR4GZ	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
904870	Internal RxNorm lookup
904876	Internal RxNorm lookup
904880	Internal RxNorm lookup
1432969	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
315284b8-32ab-d34a-ea02-f501c6131bcc	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
68654759-f50b-79ef-24c5-544d94fe7d87	Product name	3	20251114
08a295bb-88df-4ab0-a120-a75a789a74f1	Product name	1	20231013
ab841ac7-728a-4fc9-be0a-35b96cecbf39	Product name	4	20230306
100316cc-94a9-474e-97ad-9b5c6ddec605	Product name	5	20230125
539bc5d3-546b-4af6-9c31-058ce6c459d3	Product name	2	20220210
b871fccd-1de6-4c7f-b9e5-045304641ee6	Product name	8	20220118
31e16ab2-c562-4617-a3e8-ed285320e16e	Product name	1	20180201
4c23a34c-e8fc-424c-8fa0-ee064ba6eaef	Product name	1	20170706
a5920611-4285-f024-69b9-39ff338b81ea	Product name	5	20170609
3df867ed-9d48-45cf-bded-1394beaea0b1	Product name	3	20161206
973da5bf-b1f9-4de0-81ee-7ca066c98ca4	Product name	1	20160712

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
47781-419-04	2024-01-30	C162847	48780-1	1030e365-39fc-111a-e063-dadaa90a10e2	These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval: 1981

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
47781-419-04	buprenorphine transdermal system	4 in 1 CARTON	PATCH, EXTENDED RELEASE	4	4
47781-419-11	buprenorphine transdermal system	168 h in 1 PATCH	PATCH, EXTENDED RELEASE	168	4
47781-419-11	buprenorphine transdermal system	1 in 1 POUCH	PATCH, EXTENDED RELEASE	1	4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
47781-419-04	EA - Each	47781-419	9582def1-48eb-4cc7-81e7-be6f0a62120d	1	2022-11-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
47781-419	BUPRENORPHINE TRANSDERMAL SYSTEM (BUPRENORPHINE) PATCH, EXTENDED RELEASE [ALVOGEN INC.]	3	Current NDC, Legacy NDC, 3 package rows	20240316_315284b8-32ab-d34a-ea02-f501c6131bcc.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
buprenorphine transdermal system	BUPRENORPHINE	Alvogen Inc.	315284b8-32ab-d34a-ea02-f501c6131bcc	2025-09-12	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207490 application number: ANDA207490 ndc (product): 47781-419

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
40D3SCR4GZ	BUPRENORPHINE	52485-79-7	BUPRENORPHINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
904870	buprenorphine 10 MCG/HR 7 Day Transdermal System	PSN	315284b8-32ab-d34a-ea02-f501c6131bcc	4
1432969	buprenorphine 15 MCG/HR 7 Day Transdermal System	PSN	315284b8-32ab-d34a-ea02-f501c6131bcc	4
904876	buprenorphine 20 MCG/HR 7 Day Transdermal System	PSN	315284b8-32ab-d34a-ea02-f501c6131bcc	4
904880	buprenorphine 5 MCG/HR 7 Day Transdermal System	PSN	315284b8-32ab-d34a-ea02-f501c6131bcc	4
904880	168 HR buprenorphine 0.005 MG/HR Transdermal System	SCD	315284b8-32ab-d34a-ea02-f501c6131bcc	4
904870	168 HR buprenorphine 0.01 MG/HR Transdermal System	SCD	315284b8-32ab-d34a-ea02-f501c6131bcc	4
1432969	168 HR buprenorphine 0.015 MG/HR Transdermal System	SCD	315284b8-32ab-d34a-ea02-f501c6131bcc	4
904876	168 HR buprenorphine 0.02 MG/HR Transdermal System	SCD	315284b8-32ab-d34a-ea02-f501c6131bcc	4
904870	buprenorphine 10 MCG/HR 7 Day Transdermal System	SY	315284b8-32ab-d34a-ea02-f501c6131bcc	4
904870	buprenorphine 10 MCG/HR Weekly Transdermal Patch	SY	315284b8-32ab-d34a-ea02-f501c6131bcc	4
1432969	buprenorphine 15 MCG/HR 7 Day Transdermal System	SY	315284b8-32ab-d34a-ea02-f501c6131bcc	4
1432969	buprenorphine 15 MCG/HR Weekly Transdermal Patch	SY	315284b8-32ab-d34a-ea02-f501c6131bcc	4
904876	buprenorphine 20 MCG/HR 7 Day Transdermal System	SY	315284b8-32ab-d34a-ea02-f501c6131bcc	4
904876	buprenorphine 20 MCG/HR Weekly Transdermal Patch	SY	315284b8-32ab-d34a-ea02-f501c6131bcc	4
904880	buprenorphine 5 MCG/HR 7 Day Transdermal System	SY	315284b8-32ab-d34a-ea02-f501c6131bcc	4
904880	buprenorphine 5 MCG/HR Weekly Transdermal Patch	SY	315284b8-32ab-d34a-ea02-f501c6131bcc	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
47781-419-04	47781041904	4 POUCH in 1 CARTON (47781-419-04) / 1 PATCH in 1 POUCH (47781-419-11) / 168 h in 1 PATCH	4 pouch	2022-08-29	2027-01-31	No	No	Current
47781-419-11	47781041911	168 h in 1 PATCH	168 h					Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
buprenorphine transdermal system - Alvogen Inc.	Alvogen Inc.	2025-09-12	HUMAN PRESCRIPTION DRUG LABEL	4